Published in Trials on February 13, 2013
Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear | NCT02412059
The global impact of eye injuries. Ophthalmic Epidemiol (1998) 5.20
Incidence of cases of ocular trauma admitted to hospital and incidence of blinding outcome. Br J Ophthalmol (1996) 3.18
An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol (1991) 3.02
Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology (1997) 2.94
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology (2003) 2.61
The spectrum and burden of ocular injury. Ophthalmology (1988) 2.54
Severe ocular trauma managed with primary pars plana vitrectomy and silicone oil. Retina (1997) 2.48
Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol (1980) 2.09
Visual outcome and ocular survival after penetrating trauma. A clinicopathologic study. Ophthalmology (1995) 2.07
Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol (2000) 1.73
A population-based study on the incidence of severe ocular trauma in Singapore. Am J Ophthalmol (1999) 1.63
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol (1995) 1.43
Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (2005) 1.40
Anterior proliferative vitreoretinopathy. Am J Ophthalmol (1988) 1.19
Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology (2008) 1.19
Controversies in the management of open-globe injuries involving the posterior segment. Surv Ophthalmol (1999) 1.18
Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol (1984) 1.16
Postoperative retinal fibrosis--a controlled clinical study of systemic steroid therapy. Graefes Arch Clin Exp Ophthalmol (1982) 1.13
Deadly weapon-related open-globe injuries: outcome assessment by the ocular trauma classification system. Am J Ophthalmol (2000) 1.10
A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin. Ophthalmology (1988) 1.06
Steroidal and nonsteroidal anti-inflammatory agents. Effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol (1984) 1.05
Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol (1991) 1.05
[Epidemiology of open globe injuries]. Klin Monbl Augenheilkd (1999) 1.04
Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes. Invest Ophthalmol Vis Sci (2007) 1.02
Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 1.01
Breakdown and reestablishment of blood-aqueous barrier with implant surgery. Arch Ophthalmol (1982) 1.01
Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol (1996) 1.00
Glucocorticosteroid inhibition of intraocular proliferation after injury. Am J Ophthalmol (1981) 0.93
Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging (2007) 0.93
Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy. Can J Ophthalmol (2005) 0.92
Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy. Retina (1997) 0.92
Retinal detachment due to ocular penetration. I. Clinical characteristics and surgical results. Arch Ophthalmol (1978) 0.89
Traumatic retinal detachment. Mod Probl Ophthalmol (1972) 0.81
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med (2015) 6.12
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology (2010) 4.65
Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ (2010) 3.12
Evidence for superior efficacy and safety of LASIK over photorefractive keratectomy for correction of myopia. Ophthalmology (2006) 2.94
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol (2012) 2.42
Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem (2007) 2.27
Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. Ophthalmology (2007) 2.17
The associations of floppy eyelid syndrome: a case control study. Ophthalmology (2010) 2.16
Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Experiment Ophthalmol (2004) 2.16
A randomized controlled trial comparing everting sutures with everting sutures and a lateral tarsal strip for involutional entropion. Ophthalmology (2009) 2.15
Outcomes of phacoemulsification and intraocular lens implantation in microphthalmos and nanophthalmos. J Cataract Refract Surg (2013) 2.06
Outcome of external dacryocystorhinostomy combined with membranectomy of a distal canalicular obstruction. Am J Ophthalmol (2005) 1.85
A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open (2014) 1.70
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 1.69
Long-term outcome of combined pars plana vitrectomy and scleral fixated sutured posterior chamber intraocular lens implantation. Am J Ophthalmol (2006) 1.68
Optical coherence tomography analysis of the macula after vitrectomy surgery for retinal detachment. Ophthalmology (2006) 1.67
Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology (2003) 1.65
Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus. Ophthalmology (2004) 1.56
Cataract surgery after trabeculectomy: the effect on trabeculectomy function. Arch Ophthalmol (2011) 1.54
Pathogenesis of rhegmatogenous retinal detachment: predisposing anatomy and cell biology. Retina (2010) 1.53
Axial length and age at cataract surgery. J Cataract Refract Surg (2004) 1.52
Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study. Ophthalmology (2007) 1.51
Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Am J Ophthalmol (2006) 1.50
Randomized trial of multifocal intraocular lenses versus monovision after bilateral cataract surgery. Ophthalmology (2013) 1.47
Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion. Transfusion (2009) 1.46
Effect of visual acuity on biometry prediction error after cataract surgery. J Cataract Refract Surg (2003) 1.46
Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (2005) 1.40
Analysis of the macula with optical coherence tomography after successful surgery for proliferative vitreoretinopathy. Arch Ophthalmol (2005) 1.39
A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis. Br J Ophthalmol (2011) 1.39
Correspondence. Retina (2017) 1.38
Optical coherence tomography analysis of the macula after scleral buckle surgery for retinal detachment. Ophthalmology (2006) 1.38
Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Invest Ophthalmol Vis Sci (2009) 1.35
Needle revision of failing and failed trabeculectomy blebs with adjunctive 5-fluorouracil: survival analysis. Ophthalmology (2004) 1.32
The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br J Ophthalmol (2012) 1.30
A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology (2004) 1.27
Multigram synthesis of the C29-C51 subunit and completion of the total synthesis of altohyrtin C (spongistatin 2). J Am Chem Soc (2003) 1.27
Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am J Ophthalmol (2006) 1.26
Is prophylactic 360-degree laser retinopexy protective? Risk factors for retinal redetachment after removal of silicone oil. Ophthalmology (2002) 1.24
Flap and suture manipulation after trabeculectomy with adjustable sutures: titration of flow and intraocular pressure in guarded filtration surgery. J Glaucoma (2004) 1.23
Geographical variation in certification rates of blindness and sight impairment in England, 2008-2009. BMJ Open (2012) 1.22
How effective is low vision service provision? A systematic review. Surv Ophthalmol (2011) 1.20
Clinical variations in assessment of bull's-eye maculopathy. Arch Ophthalmol (2002) 1.20
Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum Mol Genet (2012) 1.18
Outcomes of surgery for posterior segment intraocular foreign bodies--a retrospective review of 17 years of clinical experience. Graefes Arch Clin Exp Ophthalmol (2006) 1.17
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev (2013) 1.17
Functional outcome and prognostic factors in 304 eyes managed by retinectomy. Graefes Arch Clin Exp Ophthalmol (2006) 1.17
Microglial cell activation following retinal detachment: a comparison between species. Mol Vis (2005) 1.15
The predisposing pathology and clinical characteristics in the Scottish retinal detachment study. Ophthalmology (2011) 1.14
Attention should be given to multiplicity issues in systematic reviews. J Clin Epidemiol (2008) 1.13
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 1.12
The epidemiology and socioeconomic associations of retinal detachment in Scotland: a two-year prospective population-based study. Invest Ophthalmol Vis Sci (2010) 1.11
Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol (2007) 1.10
Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.09
Three-year outcomes of cultured limbal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the Clinical Outcome Assessment in Surgical Trials assessment tool. Stem Cells Transl Med (2014) 1.09
The ability of rapid retinal reattachment to stop or reverse the cellular and molecular events initiated by detachment. Invest Ophthalmol Vis Sci (2002) 1.09
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology (2005) 1.08
YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial. Ophthalmology (2010) 1.08
Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials. Br J Ophthalmol (2012) 1.07
Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics (2010) 1.05
Immunopathology of intraocular silicone oil: enucleated eyes. Br J Ophthalmol (2006) 1.04
Visual function and subjective perception of visual ability after macular hole surgery. Am J Ophthalmol (2004) 1.04
Face-down positioning or posturing after macular hole surgery. Cochrane Database Syst Rev (2011) 1.04
Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev (2011) 1.03
A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol (2013) 1.03
Experimental retinal reattachment: a new perspective. Mol Neurobiol (2003) 1.03
C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. Biochem Biophys Res Commun (2003) 1.03
Pilot study of the systemic effects of three different screening methods used for retinopathy of prematurity. Early Hum Dev (2004) 1.02
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev (2012) 0.99
Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma. Cochrane Database Syst Rev (2014) 0.99
Immunopathology of intraocular silicone oil: retina and epiretinal membranes. Br J Ophthalmol (2006) 0.99
Avoidable sight loss from glaucoma: is it unavoidable? Br J Ophthalmol (2012) 0.99
The Depression in Visual Impairment Trial (DEPVIT): trial design and protocol. BMC Psychiatry (2012) 0.98
Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial. Br J Ophthalmol (2012) 0.98
Genomics of elite sporting performance: what little we know and necessary advances. Br J Sports Med (2013) 0.97
Role of ADAMTSL4 mutations in FBN1 mutation-negative ectopia lentis patients. Hum Mutat (2010) 0.96
Computerized repeating and averaging improve the test-retest variability of ETDRS visual acuity measurements: implications for sensitivity and specificity. Invest Ophthalmol Vis Sci (2011) 0.95
Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series. Arch Ophthalmol (2011) 0.94
Changing trends in the incidence of bleb-related infection in trabeculectomy. Br J Ophthalmol (2012) 0.94
Resources involved in managing retinal detachment complicated by proliferative vitreoretinopathy. Retina (2004) 0.94
No evidence of association between complement factor I genetic variant rs10033900 and age-related macular degeneration. Eur J Hum Genet (2011) 0.94
Relationships between maternal ethnicity, gestational age, birth weight, weight gain, and severe retinopathy of prematurity. J Pediatr (2013) 0.93
Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 0.93
Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis. Invest Ophthalmol Vis Sci (2012) 0.93
Attitudes and behaviours of young Indigenous people in Townsville concerning relationships, sex and contraception: the "U Mob Yarn Up" project. Med J Aust (2007) 0.92
Proliferative vitreoretinopathy: developments in pathogenesis and treatment. Compr Ophthalmol Update (2006) 0.92
Accuracy of intraocular pressure measurements in new zealand white rabbits. Invest Ophthalmol Vis Sci (2005) 0.92
Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-alpha. Am J Pathol (2002) 0.91
A comparative study between clinical grading of anterior chamber flare and flare reading using the Kowa laser flare meter. Int Ophthalmol (2012) 0.91
Interventions for involutional lower lid entropion. Cochrane Database Syst Rev (2011) 0.91
Beta blockers for glaucoma and excess risk of airways obstruction: population based cohort study. BMJ (2002) 0.91